accountWHITEHOUSE STATION, NJ (TheStreet) --U.S. regulators on Friday approved a new hepatitis C drug from Merck(MRK).
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
MERCK & CO.
Merck & Co. Inc. is one of the largest pharmaceutical companies in the world. Drug treating high cholesterol, hypertension, and heart disease are among the company’s best-sellers. Merck also makes a broad range of drugs to treat other therapeutic areas, including Propencia for male pattern baldness; Singulair for asthma, and Fosamax for osteoporosis. Merck also creates vaccines for children and adults, most recently getting FDA approval for its cervical cancer vaccine Gardasil.
Merck & Co. is part of Business Exchange, suggested by
Ginny Moore.
This topic contains
972 news
and
178 blog
items.
Read updated news, blogs, and resources about Merck & Co.. Find user-submitted articles and reactions on Merck & Co. from
like-minded professionals.
News
Recent news on this topic.
Merck & Co (MRK.N) won U.S. approval on Friday to sell a new drug considered a major advance against the liver...
City, California-based Gilead, New York-based Bristol- Myers, Abbott Laboratories of Abbott Park, Illinois, German...
It won US approval in March, following earlier delays, where Forest Laboratories has the marketing rights.
these two important vaccines,? the study authors write. by the end of 2008, CDC stats show. A Merck spokeswoman tells...
Stock quotes in this article:MRK Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today...
golimumab, is a follow-up drug to J&J' s arthritis blockbuster Remicade. Both drugs are sold in Europe by Merck...
by few physical assets and makes a product software -- that consists of pure thought. Or pillmakers like Merck (MRK)...
a leukemia-type disorder. The approach has led to three other approved blood cancer drugs from Japan's Eisai, Merck...
gained 0.9 percent. Many defensive shares have been on an upward trajectory since about mid-March. Shares of Merck...
City, California-based Gilead, New York-based Bristol- Myers, Abbott Laboratories of Abbott Park, Illinois, German...
gained 0.9 percent. Many defensive shares have been on an upward trajectory since about mid-March. Shares of Merck...
moved to curb lending and Cisco Systems Inc. forecast earnings that trailed analysts��� estimates. International...
Stock Market Stocks Snap Three-Day Winning Streak Market Activity Dow Jones Industrial Average| ^DJI Pfizer Inc.
cent, but Teck Resources Ltd. rose 0.6 per cent. Meanwhile, economically defensive U.S. stocks were strong.
also for the companies that make those same drugs, including Abbott Labs, Bristol-Myers Squibb, Gilead Sciences,...
won U.S. approval in March, following earlier delays, where Forest Laboratories has the marketing rights.
won U.S. approval in March, following earlier delays, where Forest Laboratories has the marketing rights.
study were made available by Abbott Laboratories, Boehringer Ingelheim Pharmaceuticals Inc, Bristol-Myers Squibb,...
in the United States in March, following earlier delays, where Forest Laboratories has the marketing rights.
push to seek biomarkers that can help researchers develop better treatments. Seven companies ��� Abbott Laboratories,...
in the United States in March, following earlier delays, where Forest Laboratories has the marketing rights.
March, following earlier delays, where Forest Laboratories (FRX.N: Quote, Profile, Research) has the marketing rights.
was called a Nifty Fifty investor. It bought the stocks of the best companies in America: IBM, Xerox, Merck, Coke, etc.
New research suggests that contrary to the package label for Merck���s shingles vaccine, it���s not necessary to wait...
Top Sources: Merck & Co.
- Reuters
- BusinessWeek
- Philadelphia Inquirer
- MarketWatch
- Wall Street Journal Online
- Financial Times
- businesswire.com
- Forbes.com
- latimes.com
- inpharm.com
